Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Harmony Biosciences Holdings

Harmony Biosciences
Regional

Harmony Biosciences Schedules First-Quarter Earnings Call for May 7

May 4, 2026May 2, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will report first-quarter 2026 financial results on Thursday, May 7, 2026, before the opening of U.S. financial markets.

Harmony Biosciences Schedules First-Quarter Earnings Call for May 7 Read More

Harmony Biosciences
Regional

Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook

April 26, 2026April 26, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently appointed Glenn Reicin as chief financial officer, effective immediately, and reaffirmed its 2026 net product revenue guidance of $1.0 …

Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook Read More
Harmony Biosciences
Regional

Harmony Biosciences Appoints COO, Updates Board Membership

April 12, 2026April 11, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) appointed Peter Anastasiou as chief operating officer and named Troy Ignelzi to its board of directors, while nominating Geno J. …

Harmony Biosciences Appoints COO, Updates Board Membership Read More

Harmony Biosciences
Regional

Harmony Biosciences to Present at Needham Healthcare Conference

April 10, 2026April 9, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026, at …

Harmony Biosciences to Present at Needham Healthcare Conference Read More
Harmony Biosciences
Regional

Harmony Biosciences Reports 2025 Revenue Growth, Issues 2026 Outlook

March 7, 2026March 6, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported $243.8 million in fourth-quarter 2025 revenue and $868.5 million in full-year net product revenue from its narcolepsy drug WAKIX, …

Harmony Biosciences Reports 2025 Revenue Growth, Issues 2026 Outlook Read More

Harmony Biosciences
Regional

FDA Approves Harmony’s WAKIX for Pediatric Cataplexy

March 1, 2026March 1, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences (Nasdaq: HRMY) said the U.S. Food and Drug Administration has approved a supplemental new drug application for WAKIX (pitolisant) tablets to treat cataplexy in …

FDA Approves Harmony’s WAKIX for Pediatric Cataplexy Read More
Harmony Biosciences
Regional

Harmony Biosciences to Report Q4 and Full-Year 2025 Results

February 20, 2026February 18, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) said it will report its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before U.S. …

Harmony Biosciences to Report Q4 and Full-Year 2025 Results Read More

Harmony Biosciences
Regional

Harmony’s WAKIX Surges Toward Blockbuster Status as Revenue Nears $1 Billion

January 23, 2026January 21, 2026 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) said preliminary, unaudited net product revenue for its lead narcolepsy drug WAKIX reached approximately $868 million in 2025, setting the …

Harmony’s WAKIX Surges Toward Blockbuster Status as Revenue Nears $1 Billion Read More
Harmony Biosciences
Regional

Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study

December 19, 2025December 18, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported new late-stage clinical data showing its experimental epilepsy drug EPX-100 delivered sharp and sustained seizure reductions in patients with …

Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study Read More
Harmony Biosciences
Regional

Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results

December 7, 2025December 7, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently reported encouraging data from its pivotal bioequivalence study for pitolisant gastro-resistant (GR), marking a major milestone as the company …

Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results Read More

Posts pagination

Previous 1 2 3 4 Next

Trending News

  • McCormick Pushes Tighter AI Export Controls, Cybersecurity

  • Teleflex Sets 34-Cent Quarterly Dividend for December

  • Pennsylvania Pitches $285M Plan for U.S. Space Academy

  • Chester County Education Awards Draw 425 Nominations

  • Kennett Square Weighs Housing Expansion, Parking Changes

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Matylda Szydelko

Woman Faces 10 Charges After Check Stolen From Mailbox

November 17, 2026November 17, 2026

robbery suspect

Gunpoint Robbery in Kennett Square Sparks Search for Suspect

November 17, 2026November 16, 2026

Police News

Overnight Theft Spree Hits Four North Coventry Neighborhood Streets

November 16, 2026November 16, 2026

Copyright © 2026 MyChesCo.